Results 111 to 120 of about 35,340 (222)

Hospital‐to‐home transition for children with asthma‐related hospitalizations: A study protocol for a pragmatic randomized controlled trial

Journal of Hospital Medicine, Volume 21, Issue 6, Page 700-709, June 2026.
Abstract Introduction Asthma is one of the most common chronic diseases of childhood with morbidity disproportionately affecting children across different racial and/or ethnic groups and socioeconomic statuses, specifically Black children and those living in poverty. Hospitalization for asthma is a significant risk factor for future readmissions.
Amy R. Law, Shilpa J. Patel, Janet A. Phoenix, Heather Gordish‐Dressman, Stephen J. Teach, Kavita Parikh   +5 more
wiley   +1 more source

Risk factors of hypertension in patients from Ghana

Medisan, 2017
An analytic-observational cases and controls non paired study of 150 patients assisted in the outpatient service of Ho Municipal Hospital in the Republic of Ghana was carried out during one year (from 2013 to 2014), of which 50 suffered from hypertension
Manuel de Jesús Linares Despaigne, María Mercedes Arrate Negret, Jorge Armando Poll Pineda, Vivian Molina Hechavarría, María Elia Bell Sánchez   +4 more
doaj  

Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
This graphical summary illustrates the efficacy and safety of brexpiprazole (2–4 mg) in patients with schizophrenia. The meta‐analysis demonstrates significant improvement in clinical outcomes, with reductions in Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression ‐ Severity scale (CGI‐S) scores, indicating better symptom ...
Sher Bano, Aashan Ahmad, Abdul Haseeb Mohammed, Ismailova Rushana Nurbekovna, Saja Saad, Noor Fatima, Muhammad Bilal Akbar, Zainab Salahuddin, Sadikun Nabi, Mohammad Mustafa Ababneh, Laiba Ajmal, Sidra Hariss, Hiba Manaf, Farah Saleh, Raouf Khan   +14 more
wiley   +1 more source

Assessing the Impact of Wastewater Flow Rates on SARS‐CoV‐2 RNA Detection: Insights for Environmental Surveillance and Policymaking

Environmental Quality Management, Volume 35, Issue 4, Summer 2026.
We meta‐analyzed 10 studies to assess whether influent flow rate affects SARS‐CoV‐2 RNA detection in wastewater treatment plants serving ≤60,000 inhabitants. The pooled odds ratio (2.08; 95% CI: 0.994–37; p = 0.053) showed no significant association between flow rate and detection probability.
André Felipe Bendix, Alex Batista Trentin, Deborah Catharine De Assis Leite, Betty Cristiane Kuhn, Felipe Beijamini, Simone Wendt, Flavia Regina Oliveira de Barros, Naiana Cristine Gabiatti, Juliana Morini Küpper Cardoso, Nédia de Castilhos Ghisi   +9 more
wiley   +1 more source

Transrectal vs transperineal prostate biopsy: a systematic review and meta‐analysis

BJU International, Volume 137, Issue 6, Page 958-967, June 2026.
Objective To compare transrectal ultrasonography (TRUS) and local anaesthetic transperineal (LATP) biopsy. Methods A systematic review of randomised control trials and prospective studies meeting eligibility criteria was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines. Results A total of 12
Gavin G. Calpin, Cian M. Hehir, Mariyah Alzayer, Benjamin M. MacCurtain, Fintan R. Ryan, Mohammud Shakeel Inder, Diarmaid C. Moran, David J. Galvin, Kieran J. Breen   +8 more
wiley   +1 more source

Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis

International Journal of Dermatology, Volume 65, Issue 6, Page 1185-1194, June 2026.
ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao, Litao Zhang, Liming Wu, Bin Yang, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chao Ji, Jing Sun, Yanping Qiu, Bo Chen, Jianzhong Zhang   +26 more
wiley   +1 more source

Ligation Versus Repair of Isolated Traumatic Peripheral Venous Injury: A Systematic Review and Meta-Analysis. [PDF]

Ann Vasc Dis
Shahzad N, Moosa MA, Siddiqui NA, Shaikh FA.   +3 more
europepmc   +1 more source

Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 994-1004, June 2026.
In this Phase 3 trial of Japanese patients with moderate to severe PPP (NCT05174065), significantly more patients achieved PPPASI‐50 at Week 16 with apremilast versus placebo. Patient‐reported outcomes, including pruritus and pain/discomfort, also showed significantly greater decreases at Week 16 with apremilast versus placebo.
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Bruce Strober, Melinda Gooderham, Wendy Zhang, Junichiro Shimauchi, Masafumi Yaguchi, Takeshi Kimura, Ryuichi Ogawa, Hamid Amouzadeh, Masamoto Murakami   +15 more
wiley   +1 more source

Point-of-care testing reduces antibiotic prescribing for adults with community-acquired pneumonia: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Ji W, Xie K, Zhang K, Liang Y, Wang Y, Yang H, Han Y, Yin W, Wang H.   +8 more
europepmc   +1 more source

Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1019-1029, June 2026.
In Chinese patients with moderate to severe plaque psoriasis, bimekizumab treatment was well tolerated and led to significantly higher clinical response rates versus placebo, including complete skin clearance. These findings were consistent with global studies and suggest that bimekizumab is an effective treatment option for Chinese people living with ...
Lin Cai, Xiao‐Yong Man, Jinyan Wang, Aihua Wei, Ying Chen, Delphine Deherder, Jun Gao, Bengt Hoepken, Weiwei Sun, Tingting Lei, Jianzhong Zhang, the BE SHINING Study Group   +11 more
wiley   +1 more source